Academic literature on the topic 'FSH hCG Trigger Letrozole Intrauterine insemination Unexplained infertility'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'FSH hCG Trigger Letrozole Intrauterine insemination Unexplained infertility.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "FSH hCG Trigger Letrozole Intrauterine insemination Unexplained infertility"

1

Goel, Neha, Ashok Verma, Shubham Bansal, Manjeet Kumari, Drishti, and Deeksha. "Effect of letrozole 2.5 mg or 5.0 mg for ovulation induction in intrauterine insemination in case of unexplained infertility: a randomized controlled trial." International Journal of Research in Medical Sciences 11, no. 10 (2023): 3701–5. http://dx.doi.org/10.18203/2320-6012.ijrms20233022.

Full text
Abstract:
Background: Aim was to compare effects of letrozole 2.5 mg or 5.0 mg for ovulation induction in patients with unexplained Infertility. Methods: A randomized controlled trial. 60 patients attending infertility clinic were randomly allocated into two groups-Group A received letrozole 2.5 mg and Group B received letrozole 5 mg orally for 5 days from 3rd day of cycle. The patients also received inj FSH 75 IU i/m on day 7 and 9 of the cycle and underwent follicular study on day 11, 13, 15. When the dominant follicle size reached 18 mm ovulation triggered with Inj hCG 5000 IU IM and Intrauterine ins
APA, Harvard, Vancouver, ISO, and other styles
2

Gupta, Pooja, Rashmi Sharma, Fiyazur Rehman, and Ankita Gupta. "Evaluation of Necessity of Routine Luteal Phase Support After Ovarian Stimulation by Oral Ovulogen in Intrauterine Insemination Cycles." Fertility Science and Research 12 (April 7, 2025): 8. https://doi.org/10.25259/fsr_30_2024.

Full text
Abstract:
Objectives Assisted reproductive technology aims to achieve superovulation to receive optimum outcomes. Resulting supraphysiological estradiol levels cause luteal phase defect due to feedback inhibition of FSH and LH. During intrauterine insemination, this mechanism is seldom seen. Thus, routine use of progesterone in clinical practice adds to burden of medication and cost without much evidence to recommend it. The objective was to evaluate the clinical utility of luteal support with progesterone in IUI cycles stimulated by oral ovulogens. Material and methods A total of 200 women attending in
APA, Harvard, Vancouver, ISO, and other styles
3

Alborzi, Mahshid, Khadijeh Pouya, Reza Asadi maman, Amir Fattahi, Kobra Hamdi, and Parvin Hakimi. "Dual FSH and HCG Triggering Increases Clinical Pregnancy Rate in IUI for Unexplained Infertility: A Randomized Controlled Trial." International Journal of Women's Health and Reproduction Sciences 12, no. 2 (2024): 83–88. http://dx.doi.org/10.15296/ijwhr.2024.6010.

Full text
Abstract:
Objectives: Despite advancements in the assisted reproduction technology (ART), the proportion of unexplained infertility is 30% among infertile couples. This study aimed to explore the pregnancy proportions in women with primary unexplained infertility who were given follicle-stimulating hormone (FSH) along with the human chorionic gonadotropin (hCG) trigger compared with those who were only given the hCG trigger. Materials and Methods: In this randomized controlled trial, the women eligible for intrauterine insemination (IUI) were investigated between April 1, 2022 and April 1, 2023 at Al-Za
APA, Harvard, Vancouver, ISO, and other styles
4

Hansen, Karl R., Jennifer D. Peck, R. Matthew Coward, et al. "Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial." Human Reproduction 35, no. 6 (2020): 1296–305. http://dx.doi.org/10.1093/humrep/deaa027.

Full text
Abstract:
Abstract STUDY QUESTION Are intrauterine insemination (IUI) performance characteristics and post-processing total motile sperm count (TMC) related to live birth rate in couples with unexplained infertility? SUMMARY ANSWER Patient discomfort with IUI and lower inseminate TMC were associated with a reduced live birth rate, while time from hCG injection to IUI, sperm preparation method and ultrasound guidance for IUI were not associated with live birth success. WHAT IS ALREADY KNOWN We previously determined that some baseline characteristics of couples with unexplained infertility, including fema
APA, Harvard, Vancouver, ISO, and other styles
5

Ahmed, Walid Anwar Morad. "DUAL OVULATION TRIGGERING WITH FOLLICLE-STIMULATING HORMONE AND HUMAN CHORIONIC GONADOTROPIN IN WOMEN WITH UNEXPLAINED INFERTILITY UNDERWENT LETROZOLE SUPEROVULATION AND INTRAUTERINE INSEMINATION: A RANDOMIZED CONTROLLED TRIAL." April 6, 2018. https://doi.org/10.5281/zenodo.1248774.

Full text
Abstract:
Objectives: TO determine whether a supplementary follicle-stimulating hormone (FSH) bolus given at the time of the human chorionic gonadotropin (hCG) trigger can improve the pregnancy and live birth rates in women with unexplained infertility (UI) underwent letrozole stimulated intrauterine insemination (IUI). Design: A randomized controlled trial. Patients and methods: One-hundred and eight women with primary unexplained infertility underwent combined letrozole superovulation and IUI. At the time of ovulation triggering patients were randomized into hCG trigger alone (Control group) versus co
APA, Harvard, Vancouver, ISO, and other styles
6

Sharma, R., P. Gupta, P. Upadhyaya, F. Rahman, and A. Gupta. "P-652 RCT to evaluate the necessity of routine luteal phase support after ovarian stimulation by oral ovulogens in intrauterine insemination (IUI) cycles." Human Reproduction 38, Supplement_1 (2023). http://dx.doi.org/10.1093/humrep/dead093.980.

Full text
Abstract:
Abstract Study question 1. Is it beneficial to provide luteal phase support in each IUI cycle stimulated by oral ovulogens ? Summary answer 1. Luteal phase support with progesterone makes no significant difference in clinical pregnancy rate in oral ovulogen stimulated IUI cycles. What is known already ART (assisted reproductive techniques) involves superovulation to achieve the development of multiple follicles. This produces supraphysiological E2 levels that causes feedback inhibition of FSH and LH in luteal phase leading to luteal phase defect. In IUI,only few follicles develop ,so the above
APA, Harvard, Vancouver, ISO, and other styles
7

Ling, Li, Di Xia, Yihan Jin, Renyun Hong, Jing Wang, and Yuanjiao Liang. "Effect of follicle size on pregnancy outcomes in patients undergoing first letrozole-intrauterine insemination." European Journal of Medical Research 29, no. 1 (2024). http://dx.doi.org/10.1186/s40001-024-01794-8.

Full text
Abstract:
Abstract Background Letrozole has been proven to be an effective method for inducing ovulation. However, little attention has been paid to whether the lead follicle size will affect the success rate of intrauterine insemination (IUI) with ovulation induction with alone letrozole. Therefore, we hope to investigate the effect of dominant follicle size on pregnancy outcomes on human chorionic gonadotropin (hCG) day of the first letrozole-IUI. Methods A retrospective cohort study design was employed. We included patients with anovulation or unexplained infertility undergoing first IUI treatment wi
APA, Harvard, Vancouver, ISO, and other styles
8

Chillara, Tejaswi, A. Anitha, Y. Mounika, A. Divya, Gunisetti Tejaswini, and Mattewada Himabindhu. "Role of Granulocyte Colony Stimulating Factor Effects on Unresponsive Thin Endometrium in Women Undergoing Controlled Ovarian Stimulated Intrauterine Insemination Cycles." Journal of Medicine and Health Research, February 21, 2024, 17–23. http://dx.doi.org/10.56557/jomahr/2024/v9i18554.

Full text
Abstract:
Back Ground: It is a prospective observational study that included unexplained infertility cycles with COS –IUI protocols. Thin endometrium of less than 7mm has a negative effect on pregnancy rate. Endometrial function and receptivity factors are important in the success of implantation.
 Aim: To monitor the effects of G-CSF on thin endometrium in improving endometrium thickness and pregnancy rates in G-CSF administered COS-IUI cycles.
 Methods: This study was conducted in the Laxmi Narasimha hospital IVF center under the guidence Dr. Adaboina Anitha,Hanamkonda, warangal. Thin endome
APA, Harvard, Vancouver, ISO, and other styles
9

Burks, H. R., J. D. Peck, S. Gavrizi, Z. S. Anderson, M. P. Diamond, and K. R. Hansen. "Effect of prematurely elevated late follicular progesterone on pregnancy outcomes following ovarian stimulation-intrauterine insemination for unexplained infertility: secondary analysis of the AMIGOS trial." Human Reproduction, May 31, 2024. http://dx.doi.org/10.1093/humrep/deae113.

Full text
Abstract:
Abstract STUDY QUESTION What is the relationship between late follicular phase progesterone levels and clinic pregnancy and live birth rates in couples with unexplained infertility undergoing ovarian stimulation with IUI (OS-IUI)? SUMMARY ANSWER Late follicular progesterone levels between 1.0 and <1.5 ng/ml were associated with higher live birth and clinical pregnancy rates while the outcomes in groups with higher progesterone levels did not differ appreciably from the <1.0 ng/ml reference group. WHAT IS KNOWN ALREADY Elevated late follicular progesterone levels have been associa
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!